Publications by authors named "Setareh A Williams"

Claim this Profile
B
Beyond the budget impact model: A case study for glucarpidase and the real cost of managing curable toxicities.
Setareh A Williams, Rich J Weiss

J Oncol Pharm Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Model of Uridine Triacetate Versus Supportive Care for the Treatment of Patients with Life-Threatening Early-Onset Severe Toxicity.
Jorge J Garcia, Alice Beers, Paige Reid, Salvatore Miragliotta, Suzanne Ward, Setareh A Williams

Clin Drug Investig· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study.
Deborah T Gold, Tammy Beckett, Chad Deal, Andrew L James, Mahshid Mohseni, Setareh A Williams

Osteoporos Int· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence to Support the Registration of a New Osteoporosis Medicinal Product in Europe.
Colleen Davenport, Patricia Gravel, Yamei Wang, Setareh A Williams, Alethea Wieland

Ther Innov Regul Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Health Management in Elective Orthopaedic Surgery: A Claims-Based Observational Study.
Kyle J Jeray, Setareh A Williams, Yamei Wang, Leny Pearman, Nick Pyrih

Geriatr Orthop Surg Rehabil· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Evaluation of Treatment Patterns for Osteoporosis and Outcomes After a Fragility Fracture in a Real-World Setting.
Andrea J Singer, Setareh A Williams, Leny Pearman, Yamei Wang, Nick Pyrih

J Orthop Trauma· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Management of Patients With Osteoporosis at Very High Risk of Fracture.
Benjamin W Diffenderfer, Yamei Wang, Leny Pearman, Nick Pyrih, Setareh A Williams

J Am Acad Orthop Surg· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes post fragility fracture among members of an integrated healthcare organization.
Annette L Adams, Denison S Ryan, Bonnie H Li, Setareh A Williams, Yamei Wang

Osteoporos Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Qualitative Study to Assess US Patient Preferences between new Transdermal System and Injectable Anabolic Therapies for Osteoporosis Treatment.
Charlotte Beaudart, Stuart Silverman, Deborah T Gold, Setareh A Williams, Rich Weiss

Arch Osteoporos· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a one year predictive model for secondary fractures in osteoporosis.
Setareh A Williams, Susan L Greenspan, Tim Bancroft, Benjamin J Chastek, Yamei Wang

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Burden of Osteoporosis-Related Fractures in the US Medicare Population.
Setareh A Williams, Shanette G Daigle, Richard Weiss, Yamei Wang, Tarun Arora

Ann Pharmacother· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Incident Fracture in Older Adults With Type 2 Diabetes: The Framingham Heart Study.
Alyssa B Dufour, Douglas P Kiel, Setareh A Williams, Richard J Weiss, Elizabeth J Samelson

Diabetes Care· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender Disparities in Osteoporosis Screening and Management Among Older Adults.
Sujith Ramachandran, Setareh A Williams, Richard J Weiss, Yamei Wang, Yiqiao Zhang

Adv Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density.
Paul D Miller, Steven Troy, Richard J Weiss, Miriam Annett, Jason Schense, Setareh A Williams

Clin Drug Investig· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abaloparatide Real-World Patient Experience Study.
Deborah T Gold, Richard Weiss, Tammy Beckett, Chad Deal, Robert S Epstein, Setareh A Williams

JBMR Plus· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture" [Clin Therapeut 42 (6) (2020) 1099-1107].
Kenneth G Saag, Setareh A Williams, Yamei Wang, Richard J Weiss, Jane A Cauley

Clin Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspective.
Mickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, Stuart S Silverman, Richard Weiss

Semin Arthritis Rheum· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture.
Kenneth G Saag, Setareh A Williams, Yamei Wang, Richard J Weiss, Jane A Cauley

Clin Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of osteoporotic fractures in US managed care enrollees.
Setareh A Williams, Benjamin Chastek, Kevin Sundquist, Sergio Barrera-Sierra, Deane Leader

Am J Manag Care· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fracture.
Mickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, Stuart S Silverman, Richard Weiss

Semin Arthritis Rheum· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey.
T Gold, Setareh A Williams, Richard J Weiss, Yamei Wang, Christopher Watkins

J Drug Assess· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in osteoporosis awareness and management: results from a survey of US postmenopausal women.
E Michael Lewiecki, Deane Leader, Richard Weiss, Setareh A Williams

J Drug Assess· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry.
Vibeke Strand, Paul Miller, Setareh A Williams, Katherine Saunders, Shannon Grant

Rheumatol Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.
Frank Trudo, David M Kern, Jill R Davis, Ozgur Tunceli, Siting Zhou, Setareh A Williams

Int J Chron Obstruct Pulmon Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment.
Jill R Davis, David M Kern, Setareh A Williams, Ozgur Tunceli, Bingcao Wu

J Manag Care Spec Pharm· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis